T65.813
Toxic effect of latex, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T65.813 refers to a toxic effect caused by latex, which can occur due to exposure or assault. Latex, a natural rubber substance widely used in medical devices, gloves, and various products, can sometimes trigger allergic reactions or toxic effects in sensitive individuals. While most exposures result in allergic responses, severe cases may involve toxic effects that require medical attention. This guide provides an overview of latex toxicity, its causes, symptoms, diagnosis, and treatment options to help patients better understand this condition.
Causes & Symptoms
Clinical Causes: Repeated or prolonged exposure to latex products, such as gloves, balloons, or medical equipment. Accidental ingestion or contact with latex materials in occupational or recreational settings. Direct assault involving latex exposure, which might involve intentional or accidental application leading to toxicity. Pre-existing latex allergy that progresses to a toxic effect upon significant exposure.
Key Symptoms: Skin reactions, including redness, swelling, or blistering at the contact site. Respiratory problems like wheezing, coughing, or shortness of breath. General symptoms such as nausea, dizziness, or fatigue. In severe cases, systemic symptoms such as anaphylaxis, characterized by difficulty breathing, drop in blood pressure, and loss of consciousness. Localized pain or irritation in areas where latex has contacted the skin.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical history to identify exposure to latex products and recent assault incidents. Physical examinations are performed to observe skin reactions or respiratory distress. Allergy testing, including skin prick tests or blood tests to measure latex-specific IgE antibodies, may assist in confirming latex sensitivity. Laboratory assessments help rule out other causes of symptoms. In cases of suspected toxicity from assault, forensic analysis and documentation are critical components of the diagnostic process.
Treatment Protocols: Treatment strategies focus on alleviating symptoms and preventing future exposure. Essential approaches include: - Immediate removal from exposure to latex products. - Use of antihistamines to manage allergic symptoms. - Administration of corticosteroids in cases of significant allergic reactions or inflammation. - Providing respiratory support such as oxygen therapy if breathing difficulties occur. - Emergency interventions, including epinephrine, in severe allergic reactions like anaphylaxis. - Supportive care for skin irritations, such as topical creams or soothing ointments. - Education on avoiding latex products and recognizing early signs of allergic reactions or toxicity. In cases involving assault, psychological support and legal measures may also be necessary, along with medical treatment for injuries or toxic effects.
Clinical Advice & FAQs
Billing Guidance
Is T65.813 a billable ICD-10 code?
Yes, T65.813 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T65.813?
Clinical documentation must specify the nature of Toxic effect of latex, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
